0
Research
Evaluation of community health screening participants' knowledge of cardiovascular risk factors
Leslie A. Mooney; Amy M. Franks, PharmD
J Am Pharm Assoc. 2009;49:529-537. doi:10.1331/JAPhA.2009.08120

Abstract

Objectives  To assess knowledge of cardiovascular disease (CVD) risk factors among a group of health screening participants and to compare knowledge between participants with high and low CVD risk.

Design  Cross-sectional pilot study.

Setting  Jonesboro, AR, during June 2007.

Patients  121 adult volunteers participating in a community health screening.

Intervention  34-item self-administered written questionnaire.

Main outcome measures  Ability to identify CVD risk factors and healthy values for CVD risk factors and the differences in these abilities between participants with high and low CVD risk.

Results  Participants demonstrated good knowledge of traditional CVD risk factors such as high blood pressure, high cholesterol, lack of exercise, and overweight or obese status. Knowledge of other CVD risk factors and healthy values for major CVD risk factors was limited. Participants with high CVD risk were significantly more likely to correctly identify high triglycerides as a CVD risk factor and to identify healthy values for fasting blood glucose and total cholesterol compared with participants with low CVD risk.

Conclusion  Overall, participants lacked knowledge of the risk factor status and healthy values for many CVD risk factors. Participants with high CVD risk may have better knowledge of some CVD risk factors than participants with low CVD risk. These findings highlight the need for more education to improve knowledge in both risk groups.

Sign In
APhA Members 
Welcome to JAPha.org! Please log in below using your APhA username and password. If you need to update your account information, please go to Pharmacists.org and login using your current credentials.
Username
Password


Forgot your password?
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation. 2008;117:e25–46.[PubMed][CrossRef]
 
Jafari M, Masih M, Emerson JF. The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program Pharmacotherapy. 2001;21:1403–6.[PubMed]
 
Liu Y, Mentele LJ, McDonough RP, et al. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents J Am Pharm Assoc. 2008;48:515–7.
 
Madejski RM, Madejski TJ. Cholesterol screening in a community pharmacy J Am Pharm Assoc. 1996;36:243–8.
 
Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects J Am Pharm Assoc. 2003;43:50–5.
 
Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals J Am Pharm Assoc. 2006;46:370–7[correction: J Am Pharm Assoc. 2006;46:666–7].
 
Ali F, Laurin MY, Lariviere C, et al. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels Can J Clin Pharmacol. 2003;10:101–6.[PubMed]
 
Clifford RM, Davis WA, Batty KT, Davis TME. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study Diabetes Care. 2005;28:771–6.[PubMed]
 
Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program J Am Pharm Assoc. 2003;43:149–59.
 
Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program J Am Pharm Assoc. 2003;43:173–84.
 
Guirguis LM, Johnson JA. Diabetes: are pharmacists making an impact on patient outcomes? Can Pharm J. 2003;136:24–8.
 
Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice Ann Pharmacother. 2005;39:1828–32.[PubMed]
 
Lee SSC, Cheung PYP, Chow MSS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong J Clin Pharmacol. 2004;44:632–9.[PubMed]
 
McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service Pharmacotherapy. 2006;26:248–53.[PubMed]
 
Paulos CP, Nygren CEA, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia Ann Pharmacother. 2005;39:939–43.[PubMed]
 
Ragucci KR, Fermo JD, Wessell AM, Chumney EC. Effectiveness of pharmacist-administered diabetes mellitus education and management services Pharmacotherapy. 2005;25:1809–16.[PubMed]
 
Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners Ann Pharmacother. 1997;31:713–9.[PubMed]
 
Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP) Pharmacotherapy. 2004;24:389–94.[PubMed]
 
Dracup K, McKinley S, Doering LV, et al. Acute coronary syndrome: what do patients know? Arch Intern Med. 2008;168:1049–54.[PubMed]
 
Kirkland SA, MacLean DR, Langille DB, et al. Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992 CMAJ. 1999;161:s10–6.[PubMed]
 
Potvin L, Richard L, Edwards AC. Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status CMAJ. 2000;162:s5–11.[PubMed]
 
Wagner J, Lacey K, Abbott G, et al. Knowledge of heart disease risk in a multicultural community sample of people with diabetes Ann Behav Med. 2006;31:224–30.[PubMed]
 
Rothman AJ, Kiviniemi MT. Treating people with information: an analysis and review of approaches to communicating health risk information J Natl Cancer Inst Monogr. 1999; 1999:44–51.
 
Guirguis LM, Kieser MA, Chewning BA, Kanous NL. Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes J Am Pharm Assoc. 2003;47:29–34.
 
Alm-Roijer C, Fridlund B, Stagmo M, Erhardt L. Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication J Cardiovasc Nurs. 2006;21:e24–31.[PubMed]
 
 Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) questionnaires Accessed at www.cdc.gov/brfss/questionnaires/english.htm, May 7,  2007.
 
 Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES) survey questionnaires, examination components and laboratory components, 2005-2006 Accessed at www.cdc.gov/nchs/about/major/nhanes/nhanes2005-2006/questexam05_06.htm, May 7,  2007.
 
Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States JAMA. 2001;286:1195–1200.[PubMed]
 
 American Diabetes Association, American College of Cardiology. The diabetes-heart disease link: surveying attitudes, knowledge and risk: executive summary Accessed at www.diabetes.org/uedocuments/executivesummary.pdf, August 26,  2008.
 
Christian AH, Rosamond W, White AR, Mosca L. Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study J Womens Health. 2007;16:68–81.
 
Williams A, Lindsell C, Rue L, Blomkalns A. Emergency department education improves patient knowledge of coronary artery disease risk factors but not the accuracy of their own risk perception Prev Med. 2007;44:520–5.[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints